| Kathy Deng, MD | |
|
24 East Main St, Bay Shore, NY 11706 | |
| (631) 666-6752 | |
| (631) 666-0684 |
| Full Name | Kathy Deng |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 14 Years |
| Location | 24 East Main St, Bay Shore, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548571359 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 272289 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Good Samaritan Hospital Medical Center | West islip, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chs Physician Partners Pc | 7618955667 | 508 |
News Archive
The latest C.S. Mott Children's Hospital National Poll on Children's Health finds only 40 percent of parents indicate they will get their children vaccinated against H1N1 flu - while 54 percent of parents indicate they will get their children vaccinated against seasonal flu. Among parents who do not plan to get their children vaccinated against H1N1 flu, 46 percent indicate they are not worried about their children getting H1N1 flu, while 20 percent believe H1N1 flu is not serious.
The findings of a comprehensive review of the placebo phenomenon and its consequences for clinical medicine are contained in a new article, "Placebo and the New Physiology of the Doctor-Patient Relationship," (http://bit.ly/14QfSur) published in Physiological Reviews.
Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received from the U.S. Food and Drug Administration (FDA), orphan-drug designation for AEZS-108, its doxorubicin targeted conjugate compound, for the treatment of ovarian cancer. AEZS-108 is currently in a Phase 2 trial in advanced ovarian and advanced endometrial cancer in Europe.
By combining a quantum dot with a novel carrier of the magnetic resonance imaging (MRI) agent gadolinium, a team of investigators at the University of Maastricht, in The Netherlands, has developed a nanoparticle that can spot apoptosis, or programmed cell death, using both MRI and fluorescence imaging.
› Verified 6 days ago
| Entity Name | Chs Physician Partners Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164585725 PECOS PAC ID: 7618955667 Enrollment ID: O20040708000027 |
News Archive
The latest C.S. Mott Children's Hospital National Poll on Children's Health finds only 40 percent of parents indicate they will get their children vaccinated against H1N1 flu - while 54 percent of parents indicate they will get their children vaccinated against seasonal flu. Among parents who do not plan to get their children vaccinated against H1N1 flu, 46 percent indicate they are not worried about their children getting H1N1 flu, while 20 percent believe H1N1 flu is not serious.
The findings of a comprehensive review of the placebo phenomenon and its consequences for clinical medicine are contained in a new article, "Placebo and the New Physiology of the Doctor-Patient Relationship," (http://bit.ly/14QfSur) published in Physiological Reviews.
Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received from the U.S. Food and Drug Administration (FDA), orphan-drug designation for AEZS-108, its doxorubicin targeted conjugate compound, for the treatment of ovarian cancer. AEZS-108 is currently in a Phase 2 trial in advanced ovarian and advanced endometrial cancer in Europe.
By combining a quantum dot with a novel carrier of the magnetic resonance imaging (MRI) agent gadolinium, a team of investigators at the University of Maastricht, in The Netherlands, has developed a nanoparticle that can spot apoptosis, or programmed cell death, using both MRI and fluorescence imaging.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathy Deng, MD 24 E Main St, Bay Shore, NY 11706 Ph: (631) 666-6752 | Kathy Deng, MD 24 East Main St, Bay Shore, NY 11706 Ph: (631) 666-6752 |
News Archive
The latest C.S. Mott Children's Hospital National Poll on Children's Health finds only 40 percent of parents indicate they will get their children vaccinated against H1N1 flu - while 54 percent of parents indicate they will get their children vaccinated against seasonal flu. Among parents who do not plan to get their children vaccinated against H1N1 flu, 46 percent indicate they are not worried about their children getting H1N1 flu, while 20 percent believe H1N1 flu is not serious.
The findings of a comprehensive review of the placebo phenomenon and its consequences for clinical medicine are contained in a new article, "Placebo and the New Physiology of the Doctor-Patient Relationship," (http://bit.ly/14QfSur) published in Physiological Reviews.
Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received from the U.S. Food and Drug Administration (FDA), orphan-drug designation for AEZS-108, its doxorubicin targeted conjugate compound, for the treatment of ovarian cancer. AEZS-108 is currently in a Phase 2 trial in advanced ovarian and advanced endometrial cancer in Europe.
By combining a quantum dot with a novel carrier of the magnetic resonance imaging (MRI) agent gadolinium, a team of investigators at the University of Maastricht, in The Netherlands, has developed a nanoparticle that can spot apoptosis, or programmed cell death, using both MRI and fluorescence imaging.
› Verified 6 days ago
Dr. Nicoleta Ionica, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 180 E Main St, Bay Shore, NY 11706 Phone: 631-780-7800 | |
Paul Howard Broomfield, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 375 E Main St, Ste 21, Bay Shore, NY 11706 Phone: 631-968-8288 Fax: 631-968-8268 | |
Joseph L Saraceno, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 370 East Main Street, Suite 5, Bay Shore, NY 11706 Phone: 631-666-5864 Fax: 631-666-1187 | |
Jason M Golbin, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 370 East Main Street, Bay Shore, NY 11706 Phone: 631-666-5806 Fax: 631-666-1187 | |
Dr. Marie-edouard Nathalie Desvarieux, M.D., M.S. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3 E Main St, Bay Shore, NY 11706 Phone: 631-666-2290 | |
Dr. Robert Chow, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 40 E Main St, Bay Shore, NY 11706 Phone: 631-376-6075 Fax: 631-539-4092 | |
Dr. Lawrence D. Campbell, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 32 E Main St, Bay Shore, NY 11706 Phone: 631-969-9600 Fax: 631-968-7624 |